NASDAQ:GANX | Income Statement | Gain Therapeutics, Inc.

Complete source-backed income-statement history.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$2.14M$4.68M-$4.68M-$4.57M$104,070.00-$4.68M-$0.11-$0.1142,879,54142,879,541
2026-03-31$2.76M$5.35M-$5.35M-$5.43M$183,066.00-$5.61M-$0.13-$0.1342,230,24842,230,248
2025-12-31$2.35M$4.47M-$4.47M-$4.47M$70,116.00-$4.54M-$0.11-$0.111,616,9041,616,904
2025-09-30$2.85M$4.79M-$4.79M-$4.74M$549,288.00-$5.28M-$0.15-$0.1534,998,06034,998,060
2025-06-30$2.76M$5.09M-$5.09M-$5.67M$141,205.00-$5.81M-$0.19-$0.1930,341,52330,341,523
2025-03-31$2.26M$4.37M-$4.37M-$4.43M$100,509.00-$4.53M-$0.16-$0.1628,685,41728,685,417
2024-12-31$1.22M$3.33M-$3.33M-$3.26M$504,738.00-$3.77M-$0.11-$0.111,607,9931,607,993
2024-09-30$2.62M$4.46M-$4.46M-$4.47M$10,994.00-$4.49M-$0.17-$0.1726,531,74726,531,747
2024-06-30$4.44M$8.18M-$8.18M-$8.14M$1,209.00-$8.14M-$0.42-$0.4219,215,58219,215,582
2024-03-31$2.51M$4.38M-$4.38M-$3.99M$19,874.00-$4.01M-$0.22-$0.2217,978,95117,978,951
2023-12-31$0.00$2.37M$4.41M-$4.41M-$4.71M$14,502.00-$4.72M-$0.29-$0.29669,330669,330
2023-09-30$2.37M$4.89M-$4.89M-$4.7M$21,456.00-$4.72M-$0.37-$0.3712,701,40112,701,401
2023-06-30$3.99M$7.73M-$7.73M-$7.66M$26,589.00-$7.69M-$0.62-$0.6212,387,08912,387,089
2023-03-31$55,180.00$2.79M$5.28M-$5.23M-$5.12M$16,728.00-$5.14M-$0.43-$0.4311,935,08111,935,081
2022-12-31$0.00$2.27M$4.56M-$4.56M-$4.6M$78,105.00-$4.67M-$0.39-$0.3900
2022-09-30$1.96M$4.75M-$4.75M-$4.55M$4,048.00-$4.56M-$0.38-$0.3811,883,36811,883,368
2022-06-30$95,102.00$2.58M$5.27M-$5.18M-$5.08M$9,146.00-$5.09M-$0.43-$0.4311,883,36811,883,368
2022-03-31$37,538.00$1.56M$3.33M-$3.29M-$3.27M$1,677.00-$3.27M-$0.28-$0.2811,883,36811,883,368
2021-12-31$36,341.00$1.47M$3.25M-$3.21M-$3.23M-$8,244.00-$3.22M-$0.26-$0.26578,215578,215
2021-09-30$15,971.00$2.48M$4.66M-$4.64M-$4.66M$5,114.00-$4.66M-$0.39-$0.3911,876,74511,876,745
2021-06-30$81,617.00$1.79M$3.6M-$3.51M-$3.55M$3,660.00-$3.56M-$0.30-$0.3011,876,46011,876,460
2021-03-31$5,269.00$1.42M$2.47M-$2.47M-$2.45M$3,479.00-$2.45M-$0.50-$0.504,868,9154,868,915
2020-12-31$9,139.00$975,612.00$1.62M-$1.62M-$1.66M-$1,368.00-$1.66M-$0.53-$0.53289,349289,349
2020-09-30$6,696.00$427,465.00$825,785.00-$819,089.00-$793,486.00$885.00-$794,371.00-$0.25-$0.253,203,7293,203,729
2020-06-30$6,373.00$438,868.00$538,838.00-$532,465.00-$538,839.00$4,523.00-$543,362.00-$0.27-$0.271,981,7651,981,765
2020-03-31$6,673.00$417,259.00$518,933.00-$512,260.00-$582,921.00$1,347.00-$584,268.001,981,765

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$10.21M$18.71M-$18.71M-$19.3M$861,118.00-$20.16M-$0.61-$0.6132,968,33632,968,336
2024-12-31$10.79M$20.35M-$20.35M-$19.87M$536,815.00-$20.41M-$0.89-$0.8922,881,41522,881,415
2023-12-31$55,180.00$11.52M$22.31M-$22.25M-$22.19M$79,275.00-$22.27M-$1.71-$1.7113,011,36113,011,361
2022-12-31$132,640.00$8.38M$17.92M-$17.78M-$17.5M$92,976.00-$17.59M-$1.48-$1.4811,883,36811,883,368
2021-12-31$133,928.00$7.16M$13.99M-$13.83M-$13.89M$4,008.00-$13.89M-$1.37-$1.3710,165,40410,165,404
2020-12-31$28,881.00$2.26M$3.51M-$3.48M-$3.57M$5,386.00-$3.58M-$1.33-$1.332,681,4082,681,408